Company profile
Lymphact company profile
Lymphact is a biopharmaceutical start-up focused on developing innovative personalized medical treatments. Their products and technologies are designed to harness the power of the immune system, the target-specific cellular mechanism which evolved in vertebrates during the last 450 million years, towards a permanent elimination of pathogens. After 5 years of pioneering research and development in this field, they created a new technology platform which can generate autologous and allogeneic cellular immune therapies for clinical applications: DOT-Cells®.
Business identity
- Website
- http://www.lymphact.com/
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2013-01-01, Year
Headquarters
- Headquarters
- Cataño, Cataño, Puerto Rico
- Postal code
- 7004-516
- Country code
- PR
- Continent
- North America